Cosmetic Outcome of Leishmaniasis Scar After WR279396 Application
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Primary Objectives:
Assess whether CL (caused by Leishmaniasis major) lesions treated with WR279396 improved the
cosmetic outcome compared with no treatment (natural healing)
Phase:
N/A
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command